Sanofi Consumer Healthcare India Limited (SANOFICONR.BO)
- Previous Close
4,940.10 - Open
4,940.10 - Bid 4,941.05 x --
- Ask 4,944.90 x --
- Day's Range
4,936.25 - 4,950.00 - 52 Week Range
4,360.30 - 5,399.55 - Volume
437 - Avg. Volume
400 - Market Cap (intraday)
113.746B - Beta (5Y Monthly) --
- PE Ratio (TTM)
62.75 - EPS (TTM)
78.71 - Earnings Date Apr 12, 2025
- Forward Dividend & Yield 55.00 (1.11%)
- Ex-Dividend Date Apr 28, 2025
- 1y Target Est
5,620.00
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Sanofi India Limited.
www.sanofi.com/en/Consumer-Healthcare/health-and-well-being583
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SANOFICONR.BO
View MorePerformance Overview: SANOFICONR.BO
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SANOFICONR.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SANOFICONR.BO
View MoreValuation Measures
Market Cap
114.00B
Enterprise Value
110.94B
Trailing P/E
62.99
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.92
Price/Book (mrq)
41.76
Enterprise Value/Revenue
15.49
Enterprise Value/EBITDA
43.45
Financial Highlights
Profitability and Income Statement
Profit Margin
24.98%
Return on Assets (ttm)
42.83%
Return on Equity (ttm)
75.32%
Revenue (ttm)
7.25B
Net Income Avi to Common (ttm)
1.81B
Diluted EPS (ttm)
78.71
Balance Sheet and Cash Flow
Total Cash (mrq)
3.27B
Total Debt/Equity (mrq)
7.44%
Levered Free Cash Flow (ttm)
4.25B